Female sexual interest/arousal disorder: history of diagnostic considerations and their implications for clinical practice.
Witherow-Párkányi M.
Psychiatr Hung. 2022;37(2):133-149.
Female Sexual Dysfunction.
Reed MA.
Clin Plast Surg. 2022 Oct;49(4):495-504. doi: 10.1016/j.cps.2022.06.009. Epub 2022 Aug 17.
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M, Rahman F, Puri LI, Rubin RS.
Int J Impot Res. 2022 Nov;34(7):635-641. doi: 10.1038/s41443-022-00613-0. Epub 2022 Oct 5.
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM.
Med Clin North Am. 2019 Jul;103(4):681-698. doi: 10.1016/j.mcna.2019.02.008.
Asexuality vs. sexual interest/arousal disorder: Examining group differences in initial attention to sexual stimuli.
Bradshaw J, Brown N, Kingstone A, Brotto L.
PLoS One. 2021 Dec 16;16(12):e0261434. doi: 10.1371/journal.pone.0261434. eCollection 2021.
Sexual Arousal in Obsessive-Compulsive Disorder With and Without Contamination/Washing Symptoms: A Moderating Role of Disgust Sensitivity.
Pozza A, Marazziti D, Mucci F, Grassi G, Prestia D, Dèttore D.
J Nerv Ment Dis. 2020 Sep;208(9):694-700. doi: 10.1097/NMD.0000000000001184.
Sildenafil citrate for female sexual arousal disorder: a future possibility?
Schoen C, Bachmann G.
Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25.
Women's sexual dysfunction associated with psychiatric disorders and their treatment.
Basson R, Gilks T.
Womens Health (Lond). 2018 Jan-Dec;14:1745506518762664. doi: 10.1177/1745506518762664.
Preliminary Efficacy of Topical Sildenafil Cream for the Treatment of Female Sexual Arousal Disorder: A Randomized Controlled Trial.
Johnson I, Thurman AR, Cornell KA, Hatheway J, Dart C, Brainard CP, Friend DR, Goldstein A.
Obstet Gynecol. 2024 Aug 1;144(2):144-152. doi: 10.1097/AOG.0000000000005648. Epub 2024 Jun 18.
Sexual Dysfunction in Women: A Practical Approach.
Faubion SS, Rullo JE.
Am Fam Physician. 2015 Aug 15;92(4):281-8.
